Arbutus Biopharma (ABUS) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to $905000.0.
- Arbutus Biopharma's Receivables - Net fell 4371.89% to $905000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $905000.0, marking a year-over-year decrease of 4371.89%. This contributed to the annual value of $2.4 million for FY2024, which is 3564.19% up from last year.
- According to the latest figures from Q3 2025, Arbutus Biopharma's Receivables - Net is $905000.0, which was down 4371.89% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Arbutus Biopharma's Receivables - Net ranged from a high of $2.7 million in Q1 2023 and a low of $899000.0 during Q4 2021
- Moreover, its 5-year median value for Receivables - Net was $1.7 million (2021), whereas its average is $1.7 million.
- Per our database at Business Quant, Arbutus Biopharma's Receivables - Net soared by 10289.41% in 2023 and then crashed by 4474.05% in 2025.
- Quarter analysis of 5 years shows Arbutus Biopharma's Receivables - Net stood at $899000.0 in 2021, then soared by 50.39% to $1.4 million in 2022, then surged by 31.36% to $1.8 million in 2023, then skyrocketed by 35.64% to $2.4 million in 2024, then tumbled by 62.43% to $905000.0 in 2025.
- Its Receivables - Net stands at $905000.0 for Q3 2025, versus $1.0 million for Q2 2025 and $1.2 million for Q1 2025.